Latest filing: Analysts/Institutional Investor Meet/Con. Call Updates - Global Health Limited
ObservedCompany dossier
Global Health
NSE:MEDANTA · ISIN INE474Q01031
- Close
- ₹1,432.9 29 Jul 2026
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Global Health
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest reported period: 31 Dec 2024 · revenue ₹943.4 Cr · PAT ₹142.9 Cr.
Exchange XBRLLatest ownership: promoter group 33.00% and public 66.91% as of 30 Jun 2026.
Exchange XBRLMaterial events
Open timeline →What changed recently
Observed
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Global Health Limited
NSE · conference call
Observed
Source filing Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
BSE · conference call
Observed
Source filing Global Health Ltd - 543654 - Board Meeting Intimation for Schedule Of Board Meeting For The First Quarter Ended June 30, 2026, Under Regulation 29 Of Listing Regulations.
BSE · financial results
Observed
Archived filing Certificate under SEBI (Depositories and Participants) Regulations, 2018 - Global Health Limited
NSE · exchange filing
Reported financials
Full financials →31 Dec 2024
- Revenue from operations
- ₹943.4 Cr
- Profit after tax
- ₹142.9 Cr
- EPS
- ₹5.32
Observed NSE structured filing · Consolidated
Ownership
Full shareholding →30 Jun 2026
- Promoter group
- 33.00%
- Public
- 66.91%
- Employee trust
- 0.09%
Observed NSE shareholding XBRL